Haims: Research is furthering a cure for Parkinson’s Disease | VailDaily.com

Haims: Research is furthering a cure for Parkinson’s Disease

Parkinson’s Disease is a neurodegenerative disorder that affects movement. While it most often occurs later in life, it can begin earlier on. In the U.S., Parkinson’s affects about 1 million people — 4% of whom may be people under age 50.

At this time, there is neither a cure, nor is there a treatment that may slow the progression. Rather, there are only medications that treat symptoms like a shuffling gait and movement disorders. Some of the most frequent movement disorders are called dyskinesia where muscles contract involuntarily causing jerky, rapid and twitch-like movements and dystonia, a condition that presents itself in sustained or repetitive twisting or tightening of muscle.


The specific cause of Parkinson’s is not known. However, researchers believe that genetics and environmental factors play significant roles. About 15% of people with Parkinson’s have a family history of the condition, which results from genetic mutations in various groups of genes. Environmental factors such as pesticides, herbicides, exposures to various metals (zinc and copper) and head injuries also may contribute to Parkinson’s onset.

The University of Bath, located in the United Kingdom, best explains Parkinson’s in detail: “Parkinson’s disease is characterized by a specific protein in human cells ‘misfolding,’ where it becomes aggregated and malfunctions. The protein — alpha-synuclein (αS) — is abundant in all human brains. After misfolding, it accumulates in large masses, known as Lewy bodies. These masses consist of αS aggregates that are toxic to dopamine-producing brain cells, causing them to die. It is this drop in dopamine signaling that triggers the symptoms of Parkinson’s disease, as the signals transmitting from the brain to the body become noisy, leading to the distinctive tremors seen in sufferers.”

New research suggests that defects in the blood-brains may have much to do with the development of Parkinson’s. The blood-brain barrier prevents materials from the blood from entering the brain. Normally, the blood-brain barrier acts as a vital filter that protects the brain against harmful toxins. When functioning properly, it allows nutrients to pass through and provide nourishment and detoxification.

Support Local Journalism

When the blood-brain barrier is not functioning properly, it may cause toxins to become trapped within the brain and may also allow in inflammatory cells and molecules that cause damage. Further, blood-brain barrier dysfunctions may impede glucose and other nutrients from entering.


At Georgetown University, researchers have recently found that a drug used to treat leukemia called, nilotinib, may assist in motor and nonmotor decline in Parkinson’s patients. The article, “Vascular Defects Appear to Underlie the Progression of Parkinson’s Disease,” is well worth taking the time to read.

Another article found in Nov. 12 publication of Neurology Genetics addresses how advances in technology have enabled scientist to better understand MicroRNAs (miRNAs) — a form of single-stranded RNA which thought to regulate the expression of other genes. This article is a somewhat technical read but quite educational for those interested in learning about the latest scientific breakthroughs.

An easier-to-read synopsis of this article can be found in Medical News Today titled, “Blood-brain barrier changes may explain Parkinson’s disease progression.”

Slowing the progression

Keeping mobile may be one of the best defenses against slowing the progression of Parkinson’s side effects. Daily exercise plays an extremely important role in not only slowing the disease but also in maintaining one’s ability to participate in daily activities and socialization. Consider walking, strength training, yoga, tai-chi and pilates.

Research also promotes awareness of one’s gut microbiome. Many studies indicate that compared to people without Parkinson’s, people with Parkinson’s exhibit elevated levels of the microbiome lactobacillaceae and verrucomicrobiaceae, and a decrease in the family prevotellaceae. Balancing gut microbiome plays an important role in many health-related concerns.

Before you buy any probiotic that may modify microbiome within the gut, consult your medical provider. They can interfere with medication you take. If you are interested in learning more about the correlation between Parkinson’s and gut microbiome, read an article from the American Parkinson Disease Association titled, “PD and the microbiome.”

Fabulous new developments are happening in the research of Parkinson’s. Educate yourself by going online and learning about what’s happening.

Support Local Journalism